# EDGAR Filing Document

**Accession Number:** 0001703057
**File Stem:** 0001703057-26-000023
**Filing Date:** 2026-4
**Character Count:** 1125
**Document Hash:** 5aa71a7c306c20f9409c8d36a866ec43
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001703057-26-000023.hdr.sgml**: 20260429

**ACCESSION NUMBER**: 0001703057-26-000023

**CONFORMED SUBMISSION TYPE**: ARS

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260429

**DATE AS OF CHANGE**: 20260429

**EFFECTIVENESS DATE**: 20260429

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AbCellera Biologics Inc.
- **CENTRAL INDEX KEY:** 0001703057
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** ARS
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39781
- **FILM NUMBER:** 26914775

**BUSINESS ADDRESS:**
- **STREET 1:** 150 W 4TH AVENUE
- **CITY:** VANCOUVER
- **STATE:** A1
- **ZIP:** V5Y 1G6
- **BUSINESS PHONE:** (604) 559-9005

**MAIL ADDRESS:**
- **STREET 1:** 150 W 4TH AVENUE
- **CITY:** VANCOUVER
- **STATE:** A1
- **ZIP:** V5Y 1G6

### Attached PDF Documents

**Attachment 1:** `annualreport.pdf`

_No text found in this document._